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Calcium Signaling in Cardiac Myocytes
Claire J. Fearnley1,3, H. Llewelyn Roderick1,2,3, and Martin D. Bootman1,3
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United Kingdom
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Calcium (Ca2þ) is a critical regulator of cardiac myocyte function. Principally, Ca2þ is the link
between the electrical signals that pervade the heart and contraction of the myocytes to
propel blood. In addition, Ca2þ controls numerous other myocyte activities, including
gene transcription. Cardiac Ca2þ signaling essentially relies on a few critical molecular
players—ryanodine receptors, voltage-operated Ca2þ channels, and Ca2þ pumps/transport-
ers. These moieties are responsible for generating Ca2þ signals upon cellular depolarization,
recovery of Ca2þ signals following cellular contraction, and setting basal conditions.
Whereas these are the central players underlying cardiac Ca2þ fluxes, networks of signaling
mechanisms and accessory proteins impart complex regulation on cardiac Ca2þ signals.
Subtle changes in components of the cardiac Ca2þ signaling machinery, albeit through
mutation, disease, or chronic alteration of hemodynamic demand, can have profound con-
sequences for the function and phenotype of myocytes. Here, we discuss mechanisms under-
lying Ca2þ signaling in ventricular and atrial myocytes. In particular, we describe the roles
and regulation of key participants involved in Ca2þ signal generation and reversal.
OVERVIEW OF THE CARDIAC CYCLE
The mammalian heart is a complex organconsisting of four chambers—the left and
right atria and the left and right ventricles.
Through a highly coordinated series of events,
the muscular heart pumps blood through the
pulmonary and systemic vasculature (Fukuta
and Little 2008). During diastole, all four cham-
bers are relaxed. Systole is initiated by prop-
agation of a depolarizing action potential
from the sino-atrial node located in the apex
of the right atrium, through the right and then
the left atrium. This depolarization induces
contraction of these chambers, forcing blood
into the ventricles. On reaching the atrioven-
tricular (AV) node, the depolarization pauses
for a short time period (0.1 s in humans)
to ensure completion of atrial systole. Impor-
tantly, the AV node acts as an electrical insulator
between the atria and ventricles. The AV node
prevents the transfer of aberrant contraction
patterns to the ventricles, such as the spontane-
ous electrical activity occurring during atrial
fibrillation. The lower portion of the AV node
is designated the bundle of His, which then
splits into the left and right branches, allow-
ing activation of the left and right ventricles,
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respectively. These branches give rise to thin
filaments called Purkinje fibers, composed of
noncontractile cells that distribute the action
potential to ventricular myocytes and enable
the heart to contract in a coordinated fash-
ion. Transduction of the depolarization signal
through the His-Purkinje system causes ventric-
ular systole. The contraction wave, traveling up
from the ventricular base, expels blood into
the pulmonary artery then on to the lungs, or
through the aorta into the arterial system. Ret-
rograde flow of blood is prevented by valves
between the atria and ventricles.
As indicated above, the SA node situated
at the apex of the right atrium is responsible
for initiation of the cardiac action potential.
At rest, the membrane potential starts around
–70 mV (Vm) and slowly depolarizes until an
action potential is triggered. Ca2þ signals may
play a key role in action potential generation,
although there is considerable debate regard-
ing the major mechanisms controlling the rate
of SA node depolarization (see Lakatta and
DiFrancesco 2009). One primary component
of SA node depolarization is known as If (f
stands for funny) (Brown et al. 1979), an ion
current mediated by hyperpolarizing-activated
cyclic nucleotide-gated (HCN) channels (Di-
Francesco 1993). Because this current is trig-
gered by hyperpolarization, it is activated at
the start of diastole and slowly declines
throughout the pacemaker period. HCN chan-
nels are relatively nonselective, and they there-
fore generate an inward current depolarizing
Vm toward the threshold for firing an action
potential. Intracellular Ca2þ cycling has also
been proposed to act as a primary regulator of
SA node depolarization. Imaging SA node cells
reveals spontaneous elementary Ca2þ signals
known as Ca2þ sparks arising from the SR and
preceding action potential generation (Huser
et al. 2000). Ca2þ sparks reflect the concerted
opening of a cluster of RyRs. The Ca2þ sparks
activate sodium/calcium exchange (NCX),
which promotes membrane depolarization
because three Naþ ions enter for each Ca2þ
ion that leaves. T-type Ca2þ channels (“tran-
sient current;” Cav3) may also provide a source
of Ca2þ for triggering Ca2þ sparks (Bogdanov
et al. 2001; Berridge 2003). When Vm reaches
a critical threshold (240 to 250 mV), plasma
membrane L-type Ca2þ channels are opened
(ICa,L), allowing a large influx of Ca
2þ into the
cytosol and increasing the membrane potential
to þ10 mV. It is this depolarization signal
that is transmitted from the SA node through
the cardiac conduction system, culminating in
cardiac myocyte contraction. Within the SA
node cells, ICa,L activates an outward potassium
current (IK) which hyperpolarizes the mem-
brane and curtails the action potential. The
hyperpolarization leads to activation of If,
T-type Ca2þ channels and Ca2þ sparks, to begin
the next conduction cycle.
EXCITATION-CONTRACTION COUPLING
(EC-COUPLING)
EC-coupling is the process pairing myocyte
depolarization with mechanical contraction.
Ca2þ is the critical intermediary (Bers 2008).
Indeed, since Ringer’s experiments more than
a century ago, Ca2þ has been known to be an
essential mediator of this process (Ringer
1883). As the action potential sweeps over the
heart, the plasma membrane (sarcolemma) of
each myocyte becomes depolarized (290 mV
toþ20 mV) thereby causing concerted open-
ing of L-type VOCCs (“long-lasting current;”
Cav1.2). Ca
2þ flows via the VOCCs into a
restricted space between the sarcolemma and
the underlying sarcoplasmic reticulum (SR)
known as the “junctional zone” or “dyadic
cleft.” The accumulation of Ca2þ ions during
an action potential increases the Ca2þ con-
centration within this microdomain from
100 nM to 10 mM. This elementary Ca2þ
influx signal, derived from the activation of
VOCCs is known as a “Ca2þ sparklet” (Fig. 1)
(Wang et al. 2001). The distribution of Ca2þ
sparklet magnitudes suggests that one or sev-
eral VOCCs can give rise to such signals within
myocytes (Cheng and Wang 2002).
Ca2þ sparklets themselves are not adequate
to cause substantial contraction. However,
they are sufficient to induce opening of RyRs
(type 2 RyRs) on the closely apposed SR, via a
process known as “Ca2þ-induced Ca2þ release”
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(CICR). Seminal studies in the 1970s showed
that RyR activity is dependent on cytosolic
Ca2þ levels, with low concentrations (1–
10 mM) being activatory and high concentra-
tions (.10 mM) inhibiting the channel
(Fabiato and Fabiato 1972; Fabiato 1983). The
concentration of Ca2þ at the dyadic cleft
following activation of L-type Ca2þ channels
falls within the range of that required for chan-
nel activation, thus facilitating CICR.
The activation of a cluster of RyRs, and
consequent mobilization of Ca2þ from the SR,
produces an elementary Ca2þ release signal
know as a “Ca2þ spark” (Fig. 1) (Cheng and
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Figure 1. Excitation contraction coupling in ventricular myocytes. Panel A illustrates the distribution of L-type
VOCCs (Ai) and type 2 RyRs (Aii) in a section of a ventricular myocyte. The distributions of these proteins are
essentially overlapping at the level of the light microscope. Panel B is a cartoon sequence of events leading to the
generation of a Ca2þ signal within a ventricular myocyte. A small section of a ventricular myocyte is depicted
with two T-tubule projections (T-tubule spacing 1.8 mm). During the diastolic phase (Bi), the L-type VOCCs
(red channels on the T-tubule membranes) and RyRs (blue channels on SR membrane) are silent. Arrival of the
action potential causes depolarization of the sarcolemma and activation of the L-type VOCCs thereby generating
“Ca2þ sparklets” (Bii). The Ca2þ sparklets trigger activation of the RyRs thereby producing “Ca2þ sparks” (Biii).
Panel Ci depicts the consistent, global Ca2þ responses observed in an electrically paced ventricular myocyte. The
black and gray traces indicate the Ca2þ concentration (measured with fluo4) at the center and edge of the myo-
cyte. The profile of the Ca2þ signal was essentially the same in both locations. Panel Cii illustrates what happens
in a ventricular myocyte following detubulation (using formamide treatment). Detubulation decreases the
amplitude of systolic Ca2þ transients, and provokes spatial heterogeneity of the resultant Ca2þ signals. The black
and gray traces indicate the Ca2þ concentration at the center and edge of the myocyte. Whereas the Ca2þ
responses in the edge of the myocyte were reasonably consistent, the signals in the center of the cell showed
beat-to-beat variation in amplitude. Such Ca2þ signal alternans are a potential cause of cardiac arrhythmia.
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Lederer 2008). As with Ca2þ sparklets, Ca2þ
spark magnitudes can vary, indicating that
different numbers of RyRs participate in their
generation. Release of Ca2þ through the
RyRs increases the concentration of Ca2þ to
.100 mM in the dyadic cleft. It is estimated
that 25 L-type Ca2þ channels and 100 RyRs
are closely associated within the dyadic cleft to
form a “couplon” (Bers and Guo 2005). Ca2þ
ions diffuse out of the cleft to engage the con-
tractile machinery, thereby promoting cell
shortening to provide the force for pumping
blood. During a single action potential, thou-
sands of Ca2þ spark sites are simultaneously
activated by their corresponding Ca2þ sparklet
triggers (Cheng and Lederer 2008). Diffusion
of Ca2þ ions, and their subsequent spatial and
temporal summation, produces an average
global Ca2þ increase of 500 nM to 1 mM.
Troponin C (TnC), the Ca2þ-binding compo-
nent of the contractile filaments, is sensitive
to Ca2þ concentrations over that range thereby
allowing coupling of the AP-mediated Ca2þ
transient and contraction. At the end of an
action potential Ca2þ transients are rapidly ter-
minated, and the cells return to resting diastolic
levels in preparation for the next depolarization.
In addition to L-type VOCCs, contractile
cardiac myocytes express a T-type current
(Cav3 family), which is so named because of
its transient nature. As described in the section
on pacemaking above, this current is activated
at a more negative membrane potential than
the L-type (Nowycky et al. 1985). Although
ICa,T plays a role in depolarizing SA node
cells, under normal physiological situations its
role is negligible within ventricular and atrial
cardiac myocytes as most Ca2þ enters through
the L-type channels. However, T-type VOCC
expression is up-regulated during cardiac
hypertrophy, and they may provide a critical
Ca2þ signal to drive hypertrophic remodeling.
For example, Cav3.2 knockout mice did not dis-
play cardiac hypertrophy in response to pressure
overload or angiotensin II (Chiang et al. 2009).
Skeletal muscle EC-coupling is also medi-
ated by elevations in intracellular Ca2þ, and
has some similarities to the cardiac scheme
described above. The key difference in this tissue
is Ca2þ sparklets do not trigger Ca2þ release
from the SR. Rather, L-type VOCCs (Cav1.1)
on the sarcolemma have a direct physical inter-
action with RyRs (type 1 RyRs) on underlying
SR forming the triadic junction (Rios and
Brum 1987; Block et al. 1988). Depolarization
of the sarcolemma induces a conformational
change in the VOCCs, which allosterically acti-
vates the RyRs.
REGULATION OF L-TYPE VOCCs
The channels and homeostatic processes under-
lying Ca2þ release and Ca2þ clearance are
subject to regulation by multiple signaling
pathways. These signaling pathways can rapidly
alter the amplitude and/or spatial properties
of myocyte Ca2þ signaling to acutely modulate
cardiac output. For example, L-type VOCCs
are subject to regulation by cAMP-dependent
kinase (protein kinase A; PKA) downstream
from b-adrenergic receptor stimulation, e.g.,
during the fight or flight response. PKA phos-
phorylation increases channel activity, thereby
contributing to the increased cardiac contrac-
tion (positive inotropic response) evoked by
b-adrenergic stimuli. PKA-mediated phos-
phorylation increases opening of the VOCC
by a twofold mechanism—it increases both
the number of channels in an activatable
state, and their activation probability (Catterall
2000). PKA phosphorylates Ser-1928 in the
amino terminal of the a1 subunit (Perets et al.
1996), in addition to residues on the b2 subunit
(Curtis and Catterall 1985; Gerhardstein et al.
1999). Rapid dephosphorylation of the channel
is provided by the Ser/Thr phosphatases 1 and
2A (PP1 and PP2A, respectively) (Kamp and
Hell 2000).
L-type VOCCs are also phosphorylated by
protein kinase C (PKC) in response to activa-
tion of Gq-coupled receptors, e.g., a1-adrener-
gic, endothelin, and angiotensin II receptors.
The targets for PKC phosphorylation are pro-
posed to be two Thr residues in the amino ter-
minal of the a1 subunit (Shistik et al. 1998;
McHugh et al. 2000). The effects of PKC phos-
phorylation are less clear than for PKA phos-
phorylation. It is proposed that the effect may
C.J. Fearnley et al.
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be reliant on the particular PKC isoform
activated, the expression of which varies in a
complex developmental, species-dependent,
and disease-regulated manner in the heart.
Additional regulation of the L-type Ca2þ chan-
nel is provided by cGMP-dependent protein
kinase G (PKG), which has been shown to
have an inhibitory effect, thus opposing the
effects of PKA (Hartzell and Fischmeister
1986; Abi-Gerges et al. 2001).
Inactivation of the L-type Ca2þ channel is
mediated by both membrane repolarization
and by Ca2þ itself (Ca2þ-dependent inacti-
vation, CDI). The latter acts as a negative feed-
back loop, and is thought to be the more
important of the two mechanisms (Lee et al.
1985). CDI is controlled by calmodulin
(CaM), which is constitutively bound to the
channel (Peterson et al. 1999; Qin et al. 1999).
The CaM binding site is a canonical “IQ” CaM-
binding motif within the carboxyl terminus of
the a1 subunit that binds the Ca
2þ-free form
of CaM (apo-CaM) (Rhoads and Friedberg
1997; Zuhlke and Reuter 1998). Ca2þ entering
through L-type channels during EC-coupling
binds to apo-CaM to form Ca-CaM, which
inactivates the channel (Tang et al. 2003). Inter-
estingly, Ca-CaM can also enhance Ca2þ entry
through L-type Ca2þ channels by Ca2þ-
dependent facilitation (CDF). CDF is also
dependent on the IQ motif in the cytoplasmic
tail of the a1C subunit (Zuhlke et al. 1999).
This capacity for dual regulation is caused
by the presence of both high and low affinity
Ca2þ binding sites (EF-hands) within CaM,
in the carboxyl and amino terminal lobes,
respectively. It is believed that CDI depends
on Ca2þ bound to the amino terminal EF-
hands, whereas CDF depends on the carboxyl
terminal EF hands (DeMaria et al. 2001). Sub-
sequently, it was revealed that the two lobes
of CaM can detect Ca2þ arising from distinct
sources—the high affinity carboxyl terminal
site sensing local Ca2þ arising within the nano-
domain of the channel mouth, whereas the low
affinity amino terminal lobe detects global
Ca2þ signals (Tadross et al. 2008). It therefore
appears that Ca2þ binding to apo-CaM at the
carboxyl terminus of L-type VOCCs potentiates
Ca2þ entry once a Ca2þ sparklet is forming.
However, once global Ca2þ is elevated, Ca2þ
also binds to the amino terminal lobe of
CaM leading to CDI and termination of Ca2þ
entry.
Additional modification of ICa,L is provided
by Ca2þ/CaM-dependent kinase II (CaMKII),
which potentiates the influx of Ca2þ (Anderson
et al. 1994; Xiao et al. 1994; Yuan and Bers 1994;
Wu et al. 2001b). CaMKII interacts with and
phosphorylates the carboxyl terminal of the
a1 subunit (Hudmon et al. 2005). CaMKII
remains tightly bound to the channel even in
the absence of Ca2þ, although it is only active
when it has Ca-CaM bound. Importantly,
Ca-CaM can remain bound to CaMKII, and
the kinase active, even after global Ca2þ has
declined, thereby allowing CaMKII to act as a
detector of Ca2þ spike frequency (Hudmon
et al. 2005).
REGULATION OF RyRs AND CICR
There are three mammalian RyR isoforms
(RyR1–3). RyR2 is predominant in cardiac
myocytes, with significantly lesser amounts of
RyR3. The RyR channel is a large homotetra-
meric assembly of 2 megadaltons (each
subunit has a molecular mass of 560 kDa)
(Lanner et al. 2010). Structural studies have
revealed four-fold symmetry, with a four-leaf
clover or mushroom morphology formed by
the transmembrane domain and bulky cyto-
plasmic domain (Anderson et al. 1989; Sery-
sheva 2004). Binding of Ca2þ is proposed to
cause conformational changes that evoke chan-
nel gating in a mechanism similar to that of
a camera iris, with twisting of the transmem-
brane regions opening the ion pore (Serysheva
et al. 1999).
RyRs are bound by a multitude of accessory
proteins, comprising a macromolecular signal-
ing complex. These interactions determine the
efficiency and specificity of signaling to and
from RyRs, and between other signal trans-
duction cascades. Moreover, scaffolding of
proteins to RyRs recruits and concentrates
important regulatory proteins in the junctional
zone where they are ideally located to modulate
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and/or be regulated by EC-coupling. These
interactions occur on both the lumenal and
cytosolic face of the RyR (Lanner et al. 2010).
In the lumen of the SR, RyRs interact with
calsequestrin (CSQ), the major Ca2þ binding/
storage protein of muscle. CSQ is a low-
affinity Ca2þ storage protein that maintains
the SR lumenal free Ca2þ concentration be-
tween 100–500 mM (Yano and Zarain-
Herzberg 1994; Berridge 2002). The critical
role of CSQ in Ca2þ storage was shown by the
increase or decrease in SR Ca2þ load observed
in experiments in which CSQ expression was
enhanced or suppressed, respectively (Terentyev
et al. 2003). In addition to acting as the major
Ca2þ storage protein in cardiac muscle, CSQ
also regulates RyR channel activity (Prins
and Michalak 2011). CSQ reversibly changes
between monomeric to oligomeric forms in
response to changes in luminal Ca2þ concentra-
tion. It has been suggested that CSQ oligomers
are present when the SR is replete, and that these
mainly serve to buffer Ca2þ. However, when
RyRs open and SR luminal Ca2þ declines,
Ca2þ unbinds from calsequestrin and the oligo-
meric protein dissociates. The calsequestrin
monomers bind to RyRs (via a protein inter-
mediate called triadin) and inhibit channel
activity. This is an important component of
the mechanisms that terminate Ca2þ release
during each heartbeat (Gyorke et al. 2009).
The key role of CSQ in regulating Ca2þ
storage and RyR function is highlighted by a
pathological condition known as catecholami-
nergic polymorphic ventricular tachycardia
(CPVT) that is observed in patients with CSQ
mutations. CPVT is a life-threatening form of
cardiac dysrhythmia typically brought about
by emotional or physical stress. Recessive CSQ
mutations are found in 3% of CPVT patients
(Katz et al. 2009). The effects of some CPVT-
inducing CSQ mutations on calcium fluxes in
cardiac myocytes are known. For example,
mutation of the aspartate to histidine at residue
307 in CSQ (CSQD307H) causes decreased SR
Ca2þ storage and release, and increases the
frequency of delayed afterdepolarizations
(DADs; spontaneous electrical depolarization
of cardiac myocyte independent of the SA
node-evoked AP) (Viatchenko-Karpinski et al.
2004). Another mutation, arginine to glu-
tamic acid at residue 33 (CSQR33Q), decreases
the interaction between the RyR and CSQ,
resulting in abnormal regulation of the RyR by
lumenal Ca2þ and increased Ca2þ release (Ter-
entyev et al. 2006). A substantial proportion of
CPVT patients (50%) express mutated RyRs
that have altered association with accessory
proteins.
CaM is an important regulator of the RyR in
cardiac myocytes, both in its Ca2þ bound and
Ca2þ free form (Ca-CaM and apo-CaM, respec-
tively). The binding site for CaM on the RyR
was mapped to the carboxyl terminal of the
receptor by site-directed mutagenesis (Porter
Moore et al. 1999a; Porter Moore et al.
1999b), in agreement with cryo-EM studies
(Wagenknecht et al. 1997). Binding of CaM
decreases Ca2þ efflux through these channels
(Meissner and Henderson 1987). This is
thought to be facilitated by a reduction in the
opening probability and in the Ca2þ-dependent
activation of the channel (Balshaw et al. 2001).
Further Ca2þ-dependent modification of
RyRs is provided by CaMKII-dependent phos-
phorylation. Sequence analysis revealed six
consensus phosphorylation sites in the RyR
(Zucchi and Ronca-Testoni 1997). Both Ser-
2809 (Witcher et al. 1991) and Ser-2815
(Wehrens et al. 2004) have been shown to be
crucial for CaMKII-dependent phosphoryla-
tion. CaMKII phosphorylation increases RyR
activity (Witcher et al. 1991; Wehrens et al.
2004), although some studies have contested
this idea (Lokuta et al. 1995; Wu et al. 2001a).
Phosphorylation by CaMKII is emerging as
the dominant mode of regulation of RyR activ-
ity during adrenergic stimulation and in the
greater contractility associated with increased
frequency of myocyte contraction (Wu et al.
2009; Grimm and Brown 2010).
Ca2þ release through RyRs is regulated by
interaction with FK binding proteins (FKBPs),
named because of their binding of the immu-
nosuppressant drug FK506. Cardiac myocytes
express two isoforms of the 12 kDa FKBP,
namely FKBP12 and FKBP12.6 (also known
as calstabin1 and calstabin2, respectively). The
C.J. Fearnley et al.
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cardiac RyR2 binds FKBP12.6 with a higher
affinity (Timerman et al. 1996; Jeyakumar
et al. 2001). FKBP12.6 binding stabilizes the
coordinated gating of RyR subunits within a
tetramer, thereby enabling channels to transi-
tion between the fully closed and the fully
open state, while also shifting the Ca2þ depend-
ence of channel opening to a higher Ca2þ
concentration (Bers 2004). CPVT-inducing
mutations within the type 2 RyR channel
decrease the association between the receptor
and FKBP12.6, although only under conditions
of b-adrenergic stimulation. FKBP12.6 dissoci-
ation may lead to increased Ca2þ release from
the SR (Wehrens et al. 2003).
RyRs can also be phosphorylated by PKA,
which is tethered by an A kinase anchoring
protein (mAKAP) (Marx et al. 2000). PKA-
dependent phosphorylation of the receptor
was reported to increase its responsiveness to
Ca2þ (Valdivia et al. 1995), although the precise
consequences of PKA-dependent phosphoryla-
tion have been controversial. Awidely discussed
model proposed that PKA phosphorylation of
RyRs causes dissociation of FKBP12.6, thereby
leading to increased probability of channel
opening (Marx et al. 2000; Wehrens et al.
2003). This model of RyR regulation would
not only be relevant physiologically, coupling
b-adrenergic stimulation with enhanced Ca2þ
release, but would also be important in disease
conditions in which elevated PKA phosphoryla-
tion had been reported to decrease FKBP12.6-
RyR associations and result in increased
spontaneous diastolic RyR activity and DADs.
However, the dependence of FKBP12.6 associa-
tion with the RyR on PKA phosphorylation
has been much disputed (Xiao et al. 2007).
Indeed, a recent report provides substantial
evidence that the association of FKBP12.6 inter-
action with the RyR is insensitive to the degree of
PKA phosphorylation (Guo et al. 2010).
PKA may also regulate RyR activity by
phosphorylation of Sorcin, another RyR-inter-
acting protein. Sorcin is a ubiquitously ex-
pressed 22 kDa Ca2þ binding protein that
inhibits Ca2þ release via the RyR. This inhibi-
tory effect is lost following its phosphorylation
by PKA (Lokuta et al. 1997).
A cAMP phosphodiesterase (PDE) has also
been identified within the RyR macromolecular
complex (specifically, the PDE4D3 isoform).
The presence of this enzyme provides a mecha-
nism to tightly regulate cAMP, and thus PKA
activity, in the vicinity of the receptor. The levels
of this PDE isoform have been reported to be
reduced in failing hearts (Lehnart et al. 2005).
Type 2 RyRs are associated with phospha-
tases to mediate rapid receptor dephosphoryla-
tion and return it to basal levels of activity.
For example, calcineurin is suggested to be an
accessory protein of cardiac RyRs (Bandyopad-
hyay et al. 2000), and is proposed to decrease
Ca2þ channel activity. In addition, the phos-
phatases PP1 and PP2A are associated with
cardiac RyRs (Marx et al. 2001). PP1 associates
with RyRs via an interaction with spinophilin,
whereas PP2A binds to a targeting protein
PR130, which then anchors it to RyRs (Marx
et al. 2001).
CARDIAC MYOCYTE CONTRACTION
Contraction of cardiac myocytes is facilitated
by myofilaments organized into sarcomeres,
situated along the long axis of the cell. The sar-
comere consists of myosin-containing thick fil-
aments surrounded by a hexagonal array of thin
filaments, which are made up of actin polymers
and troponin/a-tropomyosin (Tn/Tm) regula-
tory units (Parmacek and Solaro 2004). Addi-
tionally, each thin filament is separated at the
Z-line by an actin binding protein, a-actinin.
Every seventh actin monomer comprising
the thin filament is bound to a Tn/Tm complex.
Tn is composed of three subunits: TnC, Tropo-
nin I (TnI), and Troponin T (TnT) (Greaser and
Gergely 1971). TnC has a similar structure to
CaM, and contains Ca2þ binding EF-hands
(Parmacek and Solaro 2004). TnI is an inhibi-
tory subunit, and TnT constitutively interacts
with Tm. Binding of Ca2þ to TnC causes a con-
formational change in associated TnI. This en-
ables Tn/Tm to slide into the groove between
actin monomers, allowing the myosin thick
filament to bind actin, thus forming a cross-
bridge. By repetitive, transient actin-myosin
interactions and utilizing energy from ATP
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hydrolysis, the two filaments slide relative to
each other, thus shortening the cell. Coordi-
nated shortening of the entire myocyte popula-
tion by the spreading AP leads to cardiac
contraction. As cytosolic Ca2þ levels decline,
Ca2þ is released from TnC leading to cross-
bridge detachment, and the thick and thin
filaments slide past each other back to their
original positions. Cross-bridges cannot form
between the filaments as they travel past in
that direction.
Troponin proteins are regulated by phos-
phorylation, which alters their activity and
thus affects cardiac myocyte contraction. PKA
phosphorylation downstream from b-adrener-
gic stimulation is of particular importance, as
this would facilitate altered cardiac contraction
during, for example, physical exertion. Much
work has been completed in elucidating the
functional outcome of this modification, and
the consensus of opinion is that PKA phosphor-
ylation leads to increased cardiac contraction
(for a review see Metzger and Westfall 2004).
PKC phosphorylates regions on TnT and TnI.
Early studies reported divergent results regard-
ing the effects of PKC phosphorylation, al-
though more recent studies point toward an
inhibition of contractile function following
PKC phosphorylation (Takeishi et al. 1998;
Sumandea et al. 2004).
A large number of mutations have been
identified in Ca2þ-dependent contractile pro-
teins that are linked with specific cardiomyopa-
thies (reviewed in Morimoto 2008). Clinically,
cardiomyopathies can be divided into four
main groups: hypertrophic cardiomyopathy
(HCM), dilated cardiomyopathy (DCM),
restrictive cardiomyopathy (RCM), and ar-
rhythmogenic right ventricular dysplasia/cardi-
omyopathy (ARVD/C). HCM is characterized
by thickening of the ventricular walls with
accompanying decreases in ventricular cham-
ber volume. In this condition, systolic function
is preserved at the expense of diastolic function,
which is responsible for symptoms of heart
failure and death in these patients. Thickened
ventricular walls are also observed in DCM,
in addition to an increase in chamber
volume. The clinical outcomes include systolic
dysfunction, which also leads to heart failure
and sudden cardiac death. RCM is linked to
diastolic dysfunction, although there is little or
no effect on systolic function or ventricular
wall thickness. Mutations leading to all three
of these myopathies have been identified in the
contractile proteins of the sarcomere, although
interestingly none have yet been found that are
linked to ARVD/C (Morimoto 2008). Consid-
ering TnT, for example, 27 mutations have
been identified that have been linked to HCM,
which act by increasing the Ca2þ sensitivity of
cardiac muscle contraction. Two TnTmutations
have been linked to DCM, the functional conse-
quence being decreased Ca2þ sensitivity and
an increased affinity of TnT for tropomyosin.
Thirty-three mutations in TnI have been found
that are linked with HCM, DCM, and RCM,
mainly causing increased Ca2þ sensitivity and
impaired interaction of TnT with TnI. Regard-
ing TnC, a HCM-causing mutation has been
identified that abolishes its interaction with
TnI, thus losing the altered Ca2þ sensitivity
imparted by PKA-dependent phosphorylation.
Thirteen tropomyosin mutations have been
identified, leading to HCM and DCM in the
manner described previously.
Ca2þ EFFLUX
EC-coupling events are short-lived—atrial and
ventricular myocytes reach peak contraction
within a few tens of milliseconds of action
potential initiation at the SA node. After cyto-
solic Ca2þ has activated the contractile units,
it is rapidly extruded from the cytosol in prep-
aration for the following action potential
(Shannon and Bers 2004). The main efflux
mechanisms in cardiac myocytes are the plasma
membrane NCX and the sarco/endoplasmic
reticulum Ca2þ ATPase (SERCA) pump on
the SR. The plasma membrane Ca2þ ATPase
(PMCA) and the mitochondrial uniporter
may also play a more minor role. The relative
contribution of these mechanisms varies in a
species-dependent manner, for example in
rabbit ventricles 70% of cytosolic Ca2þ is
removed by SERCA2a, 28% by NCX, and the
remaining 2% by the mitochondrial uniporter.
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A similar pattern is apparent in ventricles from
dog, cat, guinea pig, and human. Alternately,
in mouse and rat ventricles, SERCA2a removes
92% of the Ca2þ, leaving only 7% for
the NCX (Bassani et al. 1994; Bers 2001). The
difference in the relative contributions of
the Ca2þ clearance pathways is reflected by
the observed kinetics of NCX activity between
different species (Sham et al. 1995). NCX cur-
rent density is lowest in myocytes from rat,
and highest in those from guinea pig. The
adaptability of this system was shown in a
recent report showing minimal cardiac dysfunc-
tion in a cardiac-specific SERCA2 KO mouse
(Andersson et al. 2009). Ca2þ fluxes were main-
tained by increased activity of the L-type Ca2þ
channel and NCX, demonstrating that these
proteins can compensate for a major reduction
in SERCA levels (,5% SERCA2 protein re-
mained in myocardial tissue 4 weeks after
gene excision).
In its forward mode, NCX uses the electro-
chemical gradient across the sarcolemma to
translocate three Naþ ions into the cytosol
and expel one Ca2þ. In this situation, NCX is
a depolarizing current. If Naþ levels are high,
the exchanger may change to its reverse mode,
and bring Ca2þ into the cell. The exchanger
was discovered around 40 years ago in the squid
giant axon (Baker et al. 1969) and in the mam-
malian heart (Reuter and Seitz 1968). Following
cloning of the canine NCX (Nicoll et al. 1990),
three isoforms were identified (NCX1-3). Of
these, NCX1 (110 kDa) is predominant in car-
diac myocytes. It is responsible for exporting
an amount of Ca2þ approximately equivalent
to the flux entering via L-type Ca2þ channels
(Bridge et al. 1990). The adaptability of cardiac
myocytes is again shown in the NCX KO mouse,
in which EC-coupling is maintained by a com-
pensatory reduction in Ca2þ influx (Pott et al.
2007).
Cardiac NCX is regulated by the concentra-
tion of cytoplasmic ions, specifically activation
by Ca2þ (Hilgemann 1990) and inhibition by
Naþ (Hilgemann et al. 1992). Maintenance of
the ionic gradient between the extracellular
space and cytosol is critical for NCX activity.
In particular, intracellular Naþ must remain
low for NCX activity. This is facilitated by the
action of the sodium potassium ATPase, which
extrudes Naþ entering the cell during the action
potential. Inhibition of this pump by cardiac
glycosides such as digoxin and ouabain results
in an accumulation of intracellular Naþ, leading
to a suppression of NCX activity and thereby
attenuating Ca2þ efflux. As a consequence,
Ca2þ transient amplitude and myocyte contrac-
tion are increased. Because of these positive
inotropic effects, digoxin has long been used
as therapy for failing heart. However, this ma-
nipulation can also lead to arrhythmia and
myocyte death.
NCX has been shown to be phosphorylated
by PKC and PKA suggesting that its activity
may be regulated by these posttranslational
modifications (Iwamoto et al. 1996; Ruknudin
et al. 2000). NCX interacts with a number of
accessory proteins. In particular, it interacts
with the transmembrane protein phospholem-
man, which exerts an inhibitory effect (Zhang
et al. 2003; Ahlers et al. 2005; Cheung et al.
2007). Phosphorylation of phospholemman is
reported to occur on residues within the cyto-
plasmic carboxyl terminal of the protein, specif-
ically Ser-68, and acts to inhibit NCX (Song
et al. 2005a; Zhang et al. 2006; Cheung et al.
2007). This appears to be mediated by PKC
and not PKA (Zhang et al. 2006). NCX has
been identified within a macromolecular
complex containing PKA and its anchoring
protein mAKAP, together with PKC and the
phosphatases PP1 and PP2A (Schulze et al.
2003), providing a robust mechanism for the
phosphorylation and regulation of NCX and/
or phospholemman.
Ca2þ reuptake into the SR is mediated by
the SERCA pump, which uses energy from
ATP hydrolysis. Molecular cloning has identi-
fied three SERCA isoforms (SERCA1–3), all
of which undergo alternative splicing. The alter-
nately spliced isoforms of SERCA2 (SERCA2a
and SERCA2b) possess distinct carboxyl termi-
nal residues. SERCA isoforms differ in their
relative affinity for Ca2þ and their transport
rates (Lytton et al. 1992). SERCA2a, the main
cardiac isoform, possesses a K1/2 of 0.4 mM;
however, in vivo, this is 0.9 mM because of
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its association with its regulatory transmem-
brane phosphoprotein, phospholamban (PLB).
Cardiac SERCA pumps are usually situated on
a region of the SR separate from the junctional
zone where the RyRs are located. During recov-
ery of a Ca2þ transient, Ca2þ is pumped into
the SR at the location of the SERCA enzymes.
The Ca2þ ions return to the dyadic SR lumen
by tunneling through the SR network.
SERCA regulation in the heart is primarily
governed by PLB. Inactive, phosphorylated
PLB exists as a pentamer. It depolymerizes
when not phosphorylated and can then interact
with SERCA (Kimura et al. 1997). Unphos-
phorylated PLB monomers decrease the affinity
of SERCA for Ca2þ (Tada et al. 1974). Sub-
sequent phosphorylation of PLB prevents its
interaction with SERCA, increasing the ap-
parent activity of the pump and the rate of
Ca2þ accumulation within the SR. PLB can be
phosphorylated on three sites: Ser-16 by PKA,
Thr-17 by CaMKII, and Ser-10 by PKC (Movse-
sian et al. 1984; Simmerman et al. 1986),
facilitating regulation by a variety of signaling
pathways. CaMKII is present in a multiprotein
complex with SERCA2a, and can directly phos-
phorylate the Ca2þ pump (Toyofuku et al. 1994;
Narayanan and Xu 1997) leading to enhanced
activity (Xu and Narayanan 1999; Xu et al.
1999). Modulation of PLB-mediated SERCA
inhibition is a major mechanism for acute
enhancement of cardiac function following
b-adrenergic receptor activation. As a result of
reduced PLB interaction with the pump, the
rates of clearance of the Ca2þ transient and
relaxation is increased (positive lusitropic
response), and SR store loading is enhanced.
Because of greater Ca2þ within the store, the
magnitude of Ca2þ fluxes is elevated thereby
producing enhanced contraction.
SUBCELLULAR ORGANIZATION OF
CARDIAC MYOCYTES
As described previously, the action potential
generated at the SA node sweeps rapidly
through the heart, coordinating cardiac con-
traction by activating atrial and then ventricu-
lar myocytes in synchrony. Within individual
myocytes, the depolarization signal culminates
in activation of the sarcomeric contractile units
by elevating intracellular Ca2þ. The spatial
properties of the Ca2þ increase depending on
the structure of the different myocytes within
the heart. For example, adult ventricular
myocytes possess numerous invaginations of
the sarcolemma, which form a regular array
of inwardly directed membranous structures
known as transverse tubules (T-tubule) (Fig. 1)
(Song et al. 2005b). T-tubules are narrow
(200 nm diameter) and occur at regular inter-
vals of 2 mm (Brette and Orchard 2003).
Additional branches project from the main
T-tubules to give a complex network of sarco-
lemmal intrusions (Ayettey and Navaratnam
1978). T-tubules are a feature of mammalian
ventricular myocytes, and are absent in the ven-
tricles of birds (Bossen et al. 1978), reptiles, and
amphibians (Bossen and Sommer 1984).
The presence of T-tubules facilitates homo-
genous Ca2þ transients during EC-coupling in
ventricular myocytes. T-tubules serve to create
dyadic junctions deep within the volume of a
ventricular myocyte. In this way, Ca2þ sparks
can be triggered simultaneously throughout a
cell. The alternative to T-tubules is observed in
neonatal myocytes and atrial myocytes, where
dyadic junctions occur solely at the periphery
of the cells (Fig. 2). T-tubules also act as impor-
tant scaffolding regions for many of the proteins
essential for Ca2þ signaling (Chase and Orchard
2011). For example, the sarcolemmal L-type
Ca2þ channels and NCX are abundant on
T-tubule membranes (Orchard and Brette
2008). It has been estimated that .75% of ICa
flows into a myocyte through the T-tubules
because of the high concentration of L-type
Ca2þ channels in this region. As mentioned in
the previous section, Ca2þ-dependent inactiva-
tion of ICa is one of the main mechanisms to
curtail Ca2þ influx. This feedback mechanism
appears to be more potent at T-tubules, mean-
ing ICa at T-tubules is large but inactivates
rapidly. In contrast, inactivation of ICa at the
peripheral sarcolemma is slower overall, result-
ing in more Ca2þ entering the cell across the
outer region of a cell than at T-tubule sites.
This prolonged Ca2þ entry occurs during the
C.J. Fearnley et al.
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latter stages of ICa, and it has been proposed to
promote SR Ca2þ loading in preparation for the
following next cycle of EC-coupling.
Cardiac myocytes display an important
homeostatic principle known as “autoregula-
tion” (Eisner et al. 1998). This is essentially a
balance between ICa, Ca
2þ release from the SR
and Ca2þ efflux via NCX. Acute changes in
any one of these fluxes will exert compensatory
changes in the others that bring systolic Ca2þ
transients back to normal levels. For example,
under conditions of increased SR, Ca2þ release
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Figure 2.Excitation contraction coupling in atrial myocytes. PanelA illustrates the distribution of L-type VOCCs
(Ai) and type 2 RyRs (Aii) in a section of an atrial myocyte. The pattern of L-type VOCC expression is clearly
different from that in ventricular cells. The distribution of RyRs is similar to that in ventricular cells, except that
there is an evident population of peripheral RyRs around the edge of the myocyte. Solely these peripheral RyRs
align with the L-type VOCCs to produce functional dyads. Panel B is a cartoon sequence of events leading to the
generation of a Ca2þ signal within an atrial myocyte. A small section of an atrial myocyte is depicted. There are
no T-tubules, but instead two prominent SR tubules with a spacing of 1.8 mm. Such SR tubules have previ-
ously denoted as “Z-tubules,” as they occupy the Z-line (just like T-tubules). During the diastolic phase (Bi), the
L-type VOCCs (red channels on the T-tubule membranes) and RyRs (blue channels on SR membrane) are silent.
Arrival of the action potential causes depolarization of the sarcolemma and activation of the L-type VOCCs
thereby generating “Ca2þ sparklets” at the periphery of the cell (Bii). The Ca2þ sparklets trigger activation of
nearby RyRs thereby producing “Ca2þ sparks” (Biii). Panel Ci depicts the gradient of Ca2þ typically observed
during electrical pacing of atrial myocytes. The Ca2þ signal at the edge of the cell (black trace) is larger and
more rapidly rising than the central response (gray trace). The extent to which the Ca2þ signal occurs in the cen-
ter of the cell (and thereby causes contraction) is dependent on the inotropic status of the cell. Application of a
b-adrenergic agonist can make atrial Ca2þ signals become homogenous.
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following RyR phosphorylation Ca2þ influx
through ICa is reduced and Ca
2þ efflux via
NCX is increased, thus maintaining the steady-
state systolic Ca2þ transient. Taking into con-
sideration that Ca2þ-dependent inactivation
following SR Ca2þ release occurs predom-
inantly at the T-tubules, and NCX is also con-
centrated in this region, it is evident that
autoregulation occurs mainly at the T-tubules.
Because of the principle of autoregulation, pro-
longed changes in inotropic status require sus-
tained changes in more than one component
of the ICa/Ca
2þ release/NCX triumvirate (Eis-
ner et al. 2009).
The T-tubular network of atrial myocytes is
generally not as well developed as that observed
in ventricular myocytes, especially in the atrial
myocytes of small mammals. The sarcolemmal
L-type Ca2þ channels of atrial myocytes provide
a triggering Ca2þ signal for a small population
of “junctional” RyRs situated below the sarco-
lemma at the periphery of the cells (Bootman
et al. 2006). The consequence of this arrange-
ment is that the initial Ca2þ influx (ICa) acti-
vates Ca2þ sparks solely from the peripheral
SR (Figs. 1 and 2). In the absence of a positive
inotropic agonist, the Ca2þ signal remains con-
fined to the cellular periphery and contraction
is minimal (Bootman et al. 2011).
In addition to the junctional RyRs, atrial
myocytes express a major population of non-
junctional RyRs that form a 3-dimensional
lattice of Ca2þ release sites within the cells
(the distribution of RyRs is actually very similar
between ventricular and atrial myocytes—the
location of L-type VOCCs is different) (Figs. 1
and 2) (Chen-Izu et al. 2006; Schulson et al.
2011). Because these nonjunctional RyRs are
not located within a dyadic junction, they are
not activated by ICa (Mackenzie et al. 2001).
However, they can be activated by CICR if the
peripheral Ca2þ signal is sufficient to act as a
trigger for a Ca2þ wave. The depth that such
centripetal Ca2þ waves propagate within an
atrial myocyte determines the extent of contrac-
tion—the deeper a Ca2þ wave spreads the more
contractile filaments will be engaged (Macken-
zie et al. 2004). The extent of atrial myocyte con-
traction is regulated by controlling the spread of
the centripetal Ca2þ waves. The atrial myocytes
in some mammalian species display a relatively
high degree of T-tubule membrane. Why some
atrial cells should rely on T-tubules when others
do not is unclear. However, it has been shown
that the presence of T-tubules within individual
atrial myocytes is correlated with cell diameter,
suggesting that tubulation acts to coordinate
Ca2þ signaling in larger cells (Smyrnias et al.
2010).
Neonatal rat ventricular myocytes are simi-
lar to atrial cells in that they lack a fully formed
T-tubule network. The T-tubules appear pro-
gressively through development (Sedarat et al.
2000). Just as with atrial myocytes, the main
region of VOCC-RyR interaction within a neo-
natal myocyte is at the periphery of the cell.
Therefore, Ca2þ signals within a neonatal myo-
cyte closely resemble those in an adult atrial
cell, and change to become homogenous Ca2þ
signals when T-tubules arise.
Ventricular myocytes from hearts that are
progressing toward failure show decreased
organization of their T-tubules, and loss of
T-tubules (Fig. 3) (He et al. 2001). As a result,
there is reduced coupling efficiency between
the L-type VOCCs on the sarcolemma and
RyRs on the underlying SR. The loss of T-tubule
membranes means that dyadic junctions are
lost and RyRs become “orphaned.” This leads
to abnormal EC-coupling characterized by an
increased propensity for arrhythmia and
decreased magnitude of the Ca2þ response
and contraction (Louch et al. 2004). EC-cou-
pling in detubulated ventricular myocytes re-
sembles that observed in atrial myocytes,
whereby Ca2þ signals are initiated at the plasma
membrane and propagate through the myocyte
by the relatively slow process of CICR (Smyrnias
et al. 2010).
ADAPTATION TO DISEASE
In response to pressure or volume overload,
damage, or genetic factors, the heart mounts
an adaptive hypertrophic response. Because
cardiac myocytes are terminally differentiated,
enlargement of the heart results mainly from
growth of existing myocytes and not as a result
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of proliferation. For many hypertrophic stimuli,
the remodeling of the heart is initially beneficial
by acting to increase cardiac output. However,
under conditions in which stress persists, for
example, because of hypertension, the remod-
eled heart undergoes a process known as
“decompensation.” Specifically, the thickness
of the ventricle wall diminishes, and the ability
of the heart to supply the cardiovascular
requirements of the organism is lost. Such
pathological cardiac hypertrophy has a poor
prognosis and leads to cardiac failure and
sudden death (Levy et al. 1990).
A widely supported hypothesis is that
changes in Ca2þ cycling mediate the hypertro-
phic response (Molkentin 2006). Although
initial modifications of Ca2þ handling are
beneficial, as the heart progresses to failure
they may contribute to pathology (Fig. 3)
(Roderick et al. 2007). A general feature of cal-
cium fluxes during adaptive hypertrophy is an
increase in the amplitudes of the Ca2þ transient,
and also of the Ca2þ sparks that underlie
them. Contributing to this is an increase in SR
store loading mediated by increased SERCA
pump activity. SERCA activity is enhanced
through several mechanisms: increased SERCA
expression, decreased PLB expression, and in-
creased PLB phosphorylation. A decrease in
NCX current and an increase in RyR activity
have also been detected during this stage of
hypertrophy.
As the heart progresses to failure, further
changes in Ca2þ regulation and flux are ob-
served. Contributing to the decreased contrac-
tility of the failing heart is a general decrease
in the amplitude of each action potential-
evoked Ca2þ transient. Underlying this reduced
Ca2þ signal are a number of factors, foremost
of which is a decrease in SERCA activity
(Fig. 3) (Hoshijima et al. 2006). SERCA activity
may be modified through a reduction in its
expression, increased PLB expression or de-
creased PLB phosphorylation. As a result of
this decrease in SERCA function, diastolic
Ca2þ is elevated (a common feature of the fail-
ing heart) while myocyte relaxation is pro-
longed and SR store content is diminished
(Roderick et al. 2007). The key contribution
of SERCA dysfunction to the decrease in
cardiac function during failure has led to
the development of viral-mediated SERCA
overexpression for gene therapy (Lyon et al.
2011).
Failing hearts are also characterized by more
arrhythmic Ca2þ signals. This is perhaps
surprising given that SR store loading—a key
determinant of RyR activity—is decreased.
RyRs isolated from failing hearts and incorpo-
rated into lipid bilayers are more spontaneously
active than RyR isolated from control hearts,
perhaps explaining this conundrum (Kubalova
et al. 2005). Indeed, myocytes from failing
hearts showed decreased store loading, in-
creased spontaneous RyR opening (observed
as Ca2þ sparks) and decreased SR Ca2þ reup-
take. Another mechanism for increased
arrhythmic Ca2þ signaling during heart failure
is the expression of inositol 1,4,5-trisphosphate
(InsP3) gated Ca
2þ release channels (InsP3Rs).
InsP3Rs are typically .50-fold less abundant
than RyR in healthy myocytes (Kockskamper
et al. 2008). However, their expression increases
significantly during hypertrophy and heart
failure. In particular, their expression within
dyadic junctions increases (Fig. 3) (Harzheim
et al. 2009, 2010). The up-regulation of InsP3Rs
provides a positive-feedback loop that can
promote further hypertrophic remodeling
(Nakayama et al. 2010). Although InsP3Rs are
not capable of mounting significant Ca2þ
signals by themselves, their location next to
RyRs within dyadic junctions means that they
can trigger CICR and thereby augment EC-
coupling. The expression of InsP3Rs may be
an initially beneficial adaptive aspect of
myocyte remodeling in that they can help to
increase systolic Ca2þ transients and evoke
greater contraction. However, concomitant
with this potentially beneficial aspect of en-
hanced InsP3R expression is an undesirable
increase in the propensity of cells to show spon-
taneous Ca2þ release events that may cause
arrhythmia. This is because of the fact that
InsP3Rs are not solely tuned to the activation
of ICa, but can open independently whenever
cytosolic InsP3 levels are sufficient (Harzheim
et al. 2009).
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Figure 3. Excitation contraction coupling in healthy and decompensated hypertrophic cardiac muscle. The
figure depicts the architecture and molecular composition of a cardiac dyad in a normal, healthy myocyte
(upper panel), a compensated hypertrophic situation (middle panel), and a decompensated failing myocyte
(lower panel). A key depicting the symbols used to represent the major players in EC-coupling is provided at
the bottom of the figure. Depolarization of the plasma membrane results in Ca2þ influx through L-type voltage
gated channels in the T-Tubule, which stimulates Ca2þ release via RyRs located on the juxtaposed SR. Following
diffusion out of the dyadic cleft, Ca2þ encounters the contractile filaments causing myocyte contraction.
Myocyte relaxation is then brought about by Ca2þ recycling back into the SR by the SERCA pump or extrusion
across the plasma membrane via NCX. (See facing page for legend.)
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The importance of cellular architecture to
EC-coupling is highlighted by its contribution
to Ca2þ dysregulation during cardiac failure.
In myocytes from failing heart, the synchro-
nicity of the initiation of the Ca2þ transient is
reduced and the amplitude of the transient
diminished (Gomez et al. 1997). Work from a
number of laboratories using live and fixed
cell staining approaches, have now established
that T-tubules are lost or atrophied as hypertro-
phy develops, whereas the distribution of RyRs
on the SR is unaffected (Gomez et al. 2001;
Song et al. 2005b). As a consequence of this
membrane remodeling, RyRs become progres-
sively orphaned. Deficiencies in EC-coupling
because of T-tubule remodeling have also been
observed during the earlier stages of hypertro-
phy, albeit with less dramatic consequences
(Xu et al. 2007). During this stage, the width
of the dyadic cleft is marginally increased, alter-
ing the kinetic properties of coupling between
membrane depolarization and Ca2þ release
from the SR. Inotropic stimuli such as adrena-
line, which serve to increase Ca2þ influx and
sensitivity of RyRs to release, overcome this
deficiency in EC-coupling thus indicating that
the Ca2þ signaling machinery is still intact. Sim-
ilarly, dyadic InsP3Rs, which as indicated earlier
are elevated during hypertrophy, may also con-
tribute to overcoming the decreased efficiency
of coupling.
CONCLUSION
The raison d’etre of cardiac myocytes is con-
trolled contraction in response to repetitive
electrical depolarization signals—a function
that is fundamentally controlled by Ca2þ.
Although there are a limited number of key
players—ICa, NCX, SERCA, RyRs, TnC—
involved in generating and reversing Ca2þ sig-
nals, they are subject to numerous levels of
regulation and an array of interactions with
other proteins. Furthermore, the cellular loca-
tion of the Ca2þ signaling systems is critical in
determining the spatial properties of the Ca2þ
signals during EC-coupling. Cardiac Ca2þ sig-
nals can be acutely altered to provide rapid
changes in cardiac output. The heart responds
to long-term increased hemodynamic demand
by remodeling. This remodeling encompasses
both structural changes and altered gene expres-
sion. Depending on the stimulus, this can be an
adaptive, reversible remodeling that promotes
Ca2þ signaling and cardiac function. Alterna-
tively, a heart can become committed to an
Figure 3. (Continued) Neurohormonal activation of Gaq-coupled receptors leads to the formation of InsP3,
which stimulates Ca2þ release via InsP3Rs located in the dyad. This InsP3-stimulated Ca
2þ release sensitizes
neighboring RyRs, causing enhanced Ca2þ fluxes and increasing the frequency of arrhythmic events. Activation
of b-adrenergic receptors increases intracellular cAMP, which activates PKA leading to phosphorylation of PLB.
On phosphorylation, PLB dissociates from SERCA thereby enhancing Ca2þ transport activity. Compensated/
adaptive hypertrophy is associated with enhanced EC-coupling. Significantly contributing to this phenotype
is an increase in SR store loading. This is brought about by an up-regulation of SERCA activity mediated by
either an increase in SERCA or decrease in PLB expression. Alternatively, as a result of PKA-dependent phos-
phorylation, PLB interaction with SERCA and suppression of Ca2þ transport may also be decreased. Increased
SERCA activity also serves to increase the rate of relaxation thereby allowing more rapid cycles of myocyte con-
traction. The width of the dyadic cleft may also marginally increase at this stage of hypertrophic remodeling.
However, IP3Rs are up-regulated in the dyad during hypertrophy supplementing the Ca
2þ signal arising via
RyRs to possibly further support EC-coupling. During decompensated hypertrophy, myocyte architecture
and protein expression are remodeled. Specifically, the width of the dyadic cleft is increased making it harder
for Ca2þ arising via VOCCs to activate Ca2þ release from RyRs. T-Tubules also atrophy resulting in orphaned
RyRs. The SERCA-PLB ratio is also modified to favor decreased SERCA activity. Notably, InsP3R expression in
the dyad is increased. As a result, more of the RyRs that are located in this region are close enough to InsP3Rs to
be affected by Ca2þ arising from them. Overactivation of these InsP3Rs, for example, by the elevated levels of
circulating ET-1 present during heart failure, promotes arrhythmias thereby contributing to the pathology asso-
ciated with heart failure.
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irreversible form of remodeling that causes pro-
gressively weaker and more arrhythmic Ca2þ
signaling. The remodeling causes changes in
Ca2þ signaling and vice versa. Therefore, within
the context of the heart Ca2þ is very much a sig-
nal for both life and death.
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